November 25, 2022
1 min watch
Save
VIDEO: Combination of oral, gene therapies may be best path for geographic atrophy
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
NEW YORK — In this video, David Eichenbaum, MD, director of research at Retina Vitreous Associates of Florida, discussed the outlook for oral therapies in the treatment of geographic atrophy at OSN New York Retina.
Eichenbaum said that oral therapies might provide an easier experience for patients over gene therapies and could ideally work in concert with other therapy programs.
“The ultimate path to treatment may actually include a combination of these therapies inhibiting complement in multiple different ways,” Eichenbaum said.
Published by:
Sources/Disclosures
Collapse
Source:
Healio Interviews
Disclosures:
Eichenbaum reports consulting for Genentech.
Read more about
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.